Two patients received only three NAT infusions following delivery before they were switched to another DMT due to positive John Cunningham Virus serostatus with increased risk for progressive multifocal leukoencephalopathy. This evidence concerns the gene BRD2 and progressive multifocal leukoencephalopathy.